Clinical Trials in San Antonio

Showing 8501-8520 of 14,633 trials

SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2

NCT02592421

In Protocol 2, the investigators will determine the role of pancreatic hormones (increase in plasma glucagon and decrease in plasma insulin concentration) in the stimulation of EGP following SGLT2 inhibition.

Type II Diabetes Mellitus

The University of Texas Health Science Center at San Antonio30 participantsStarted Oct 2015

San Antonio, Texas, United States

COMPLETEDPhase 1< 1 mile

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

NCT02185794

The primary objective of the study is to evaluate the safety and tolerability of voxilaprevir (formerly GS-9857) alone or with sofosbuvir (SOF)/velpatasvir (VEL) fixed dose combination (FDC) and antiviral activity of voxilaprevir in adults with genotype 1, 2, 3, 4 hepatitis C virus (HCV) infection. All participants will be monitored for up to 48 weeks after the last dose.

Hepatitis C Virus Infection

Gilead Sciences101 participantsStarted Jun 2014

Costa Mesa, California, United States • DeLand, Florida, United States • Orlando, Florida, United States +8 more locations

COMPLETEDPhase 2< 1 mile

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

NCT03389308

The primary objective of this study is to evaluate the long term safety and tolerability of diacerein 1% ointment for 2 treatment cycles in subjects with EBS that previously participated in the CCP-020-301 or the CCP-020-101 studies.

Epidermolysis BullosaEpidermolysis Bullosa Simplex

Castle Creek Pharmaceuticals, LLC51 participantsStarted Dec 2017

Chicago, Illinois, United States • Chapel Hill, North Carolina, United States • San Antonio, Texas, United States

SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

Find Trials by Condition in San Antonio

PROMINENT-Eye Ancillary Study (Protocol AD)

A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

Dose Finding Study to Treat High Phosphate Levels in the Blood.

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001

Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors

Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)

Oral Iron for Erythropoietic Protoporphyrias

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma

Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma

A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation